Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9066883
Administration of cells and cellular extracts for rejuvenation
granted -
US 9066855
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
granted -
US 9066900
Interferon-β production modulating listeria strains and methods for using same
granted -
CA 2934118
PROPIONATE DE CORTEXOLONE-17' DESTINE A ETRE UTILISE DANS LE TRAITEMENT DE LESIONS CUTANEES ET/OU DE TROUBLES DE LA PEAU ATROPHIQUE
granted -
EP 2886116
Benzodioxol-Derivate zur Verwendung in der Behandlung von Aufmerksamkeitsdefizitstörung und/oder Hyperaktivität
granted -
US 9061016
Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
granted -
US 9062068
Protein kinase C inhibitors and uses thereof
granted -
US 9062347
Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy
granted -
US 9062002
Substituted pyridine derivatives as FabI inhibitors
granted -
US 9060971
Combination pharmaceutical agents as inhibitors of HCV replication
granted -
US 9061026
Oligomer-diarylpiperazine conjugates
granted -
US 9062297
Yersinia pestis vaccine
granted -
US 9062288
Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes
granted -
US 9062095
Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies
granted -
US 9063125
Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides
granted -
US 9062075
Tetrahydropyridine derivatives as FabI inhibitors
granted -
US 9060941
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
granted -
US 9062310
Compositions and methods for inhibiting expression of factor VII gene
granted -
US 9062093
Peptide compositions and methods for treating patients
granted -
US 9062008
Compounds useful as inhibitors of ATR kinase
granted -
US 9060995
Treatment of circadian rhythm disorders
granted -
US 9061063
Biodegradable lipids for the delivery of active agents
granted -
US 9062007
Cyclic amide BACE-1 inhibitors having a benzamide substituent
granted -
US 9062052
Carboxamide compounds and methods for using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.